Vaccination Coverage for Teens Similar in 2023 and 2022
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 26, 2024 -- In 2023, vaccination coverage for adolescents with all routine vaccines was similar to coverage in 2022, according to research published in the Aug. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from the 2023 National Immunization Survey-Teen for 16,658 adolescents aged 13 to 17 years to examine vaccination coverage in 2023, recent trends in coverage by birth year, and trends in coverage by Vaccine for Children (VFC) program eligibility.
The researchers found that coverage with all routine vaccines recommended for adolescents was similar in 2023 and 2022. Among VFC-eligible adolescents, vaccination coverage was generally stable during the COVID-19 pandemic, except for a decrease in the percentage who were up to date with human papillomavirus (HPV) vaccination by age 13 years among those born in 2010 versus 2007. Before the COVID-19 pandemic, there were differences in coverage between VFC-eligible and non-VFC-eligible adolescents, but in the most recent birth years in the survey, coverage was similar.
"Health care providers should strongly recommend all routine vaccines and confirm adolescents are fully vaccinated," the authors write. "Parents of adolescents should schedule a well-child visit as the school year begins to verify that adolescents receive all recommended vaccines, such as the HPV vaccine, which prevents 92 percent of HPV-attributable cancers."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab
TUESDAY, July 22, 2025 -- Despite near universal availability of nirsevimab, only 35 percent of eligible children receive nirsevimab for respiratory syncytial virus (RSV)...
2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
FRIDAY, July 18, 2025 -- There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS...
No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines
TUESDAY, July 15, 2025 -- Early childhood exposure to aluminum-adsorbed vaccines is not associated with an increased risk for autoimmune, atopic or allergic, or neurodevelopmental...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.